| Product NDC: | 0054-0025 |
| Proprietary Name: | Mefloquine Hydrochloride |
| Non Proprietary Name: | mefloquine hydrochloride |
| Active Ingredient(s): | 250 mg/1 & nbsp; mefloquine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0054-0025 |
| Labeler Name: | Roxane Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076523 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20041001 |
| Package NDC: | 0054-0025-11 |
| Package Description: | 1 BOTTLE in 1 CARTON (0054-0025-11) > 25 TABLET in 1 BOTTLE |
| NDC Code | 0054-0025-11 |
| Proprietary Name | Mefloquine Hydrochloride |
| Package Description | 1 BOTTLE in 1 CARTON (0054-0025-11) > 25 TABLET in 1 BOTTLE |
| Product NDC | 0054-0025 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mefloquine hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20041001 |
| Marketing Category Name | ANDA |
| Labeler Name | Roxane Laboratories, Inc. |
| Substance Name | MEFLOQUINE HYDROCHLORIDE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antimalarial [EPC] |